Bafna Pharmaceuticals Q2 Results
- BSE: 532989
- NSE: BAFNAPH
- ISIN: INE878I01022
- Sector: Biotechnology & Drugs
BSE
468.65
9.15 (1.99%)
9.15 (1.99%)Volume72.95 K
Updated: Fri 16 Oct, 2026 | 15:15:00
NSE
461.359.00 (1.99%)
9.00 (1.99%)Volume20.75 K
Updated: Fri 16 Oct, 2026 | 15:14:22
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Bafna Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 32.66 | 27.48 | 5.61% | 38.11 | -14.29% |
| Depreciation/ Amortization | 1.47 | 1.78 | 7.50% | 1.58 | -6.50% |
| Operating Income | 2.81 | -0.90 | -24.04% | 2.22 | 26.68% |
| Net Income | 3.12 | 0.08 | -7.79% | 2.62 | 19.39% |
| Other Operating Expenses Total | 2.63 | 2.59 | 75.87% | 3.72 | -29.19% |
| Net Income Before Taxes | 3.12 | 0.08 | -7.79% | 2.62 | 19.39% |
| Total Revenue | 35.47 | 26.58 | 2.44% | 40.32 | -12.04% |
| Selling/ General/ Admin Expenses Total | 5.49 | 5.62 | -2.65% | 5.06 | 8.61% |
| Diluted Normalized EPS | 1.32 | 0.03 | -7.69% | 1.11 | 18.92% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.